Chr. 12

Cidegen

Delivery time

<1 week

Sample

Blood. Biopsy tissue. Bone marrow

166,98€

Trisomy 12. Intermediate risk in B-cell chronic lymphocytic leukemia (15-20%). Marker of intermediate prognosis. Therapy with Bruton's tyrosine kinase inhibitors.

Other tests

Trisomy 11 (Blood. Biopsy tissue)

Trisomy 11 (Blood. Biopsy tissue)

166,98€

Trisomy 11 (Blood. Biopsy tissue. Bone marrow)

Trisomy 11 (Blood. Biopsy tissue. Bone marrow)

166,98€

Sequencing of exons 9, 11, 13 and 14 of the POLE gene. (Analysis in biopsy tissue)

Sequencing of exons 9, 11, 13 and 14 of the POLE gene. (Analysis in biopsy tissue)

932,31€